Ceva uses creative thinking in new approach to innovation in Industrial equity >
Libourne, France 2nd May 2013: Most of the time innovation in the bio-pharmaceutical field is associated with the scientific R&D teams. But having the latest technology vaccines is of little value if you cannot produce them efficiently, on time and to the highest quality standards. As a result, Ceva recently organized its first industrial innovation day – entitled Together, Creative Innovation,...
Ceva records double digit growth for 3rd. successive year >
14% growth pushes sales beyond 600 M€ for first time
AXA Private Equity provides additional financing to support the development of Ceva >
AXA Private Equity, the leading European diversified private equity firm, announces today that it is providing €100 million of additional financing to support the development of Ceva.
Mid-year results : Innovation drives Ceva’s growth >
Double-digit growth confirms long term upward trend
Ceva organized 2nd Swine Reproduction Symposium >
Ceva Santé Animale gathers 150 experts from 18 countries in swine reproduction symposium
Sow Reproduction Symposium - Berlin, 18-19th April >
Managing sow reproduction to maximize the outcome of pig producers
Ceva continues rapid growth in 2011 >
Twin pillar strategy of combining internal and external growth opportunities drives further global expansion
Second joint Human and Veterinary Cardiology Symposium >
Together for health, in the heart of Bordeaux
Ceva acquires Vetech Laboratories, Inc. >
Move adds significant poultry vaccine to innovative portfolio
Ceva acquires CentaurVA Animal Health >
Company continues to expand its North American operations with entry into Canada.